Literature DB >> 1554947

Comment: Myasthenia gravis and ciprofloxacin.

D S Maddix, A Stefani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1554947     DOI： 10.1177/106002809202600229

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  2 in total

1.  Probable exacerbation of myasthenia gravis by ofloxacin.

Authors:  E Azevedo; J A Ribeiro; J Polónia; C Pontes
Journal:  J Neurol       Date:  1993-09       Impact factor: 4.849

Review 2.  Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Authors:  S Christopher Jones; Alfred Sorbello; Robert M Boucher
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.